A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.
Schweizer MT, Haugk K, McKiernan JS, Gulati R, Cheng HH, Maes JL, Dumpit RF, Nelson PS, Montgomery B, McCune JS, Plymate SR, Yu EY.
Schweizer MT, et al. Among authors: nelson ps.
PLoS One. 2018 Jun 1;13(6):e0198389. doi: 10.1371/journal.pone.0198389. eCollection 2018.
PLoS One. 2018.
PMID: 29856824
Free PMC article.
Clinical Trial.